Boron Neutron Capture Therapy Market Report 2026

Boron Neutron Capture Therapy Market Overview

• Boron Neutron Capture Therapy market size has reached to $0.12 billion in 2025 • Expected to grow to $0.28 billion in 2030 at a compound annual growth rate (CAGR) of 17.7% • Growth Driver: Surge In Global Cancer Prevalence Driving The Market Demand For Advanced Targeted Cancer Therapies • Market Trend: Advancement Accelerator-Based Neutron Source Technologies To Expand Clinical Deployment Of Boron Neutron Capture Therapy • Asia-Pacific was the largest region and fastest growing region.

What Is Covered Under Boron Neutron Capture Therapy Market?

Boron neutron capture therapy is a cancer treatment that targets tumor cells using a special boron compound and neutron radiation. When exposed to neutrons, the boron reacts to produce energy that destroys cancer cells while minimizing harm to healthy tissue. The main types of boron neutron capture therapy are thermal beam and epithermal beam. Thermal beam refers to low-energy neutrons used in treatment that interact with boron compounds to selectively destroy cancer cells while minimizing damage to surrounding healthy tissue. These therapies utilize different boron agent types, including boronophenylalanine (BPA), sodium borocaptate (BSH), and next-generation boron delivery agents, and are based on various technologies, such as reactor-based boron neutron capture therapy and accelerator-based boron neutron capture therapy. They are applied across multiple applications, including brain tumor, extracranial tumor, and other applications, and are used by different end-users, such as hospitals, cancer research institutes, specialty clinics, and other end-users.

What Is The Boron Neutron Capture Therapy Market Growth Forecast?

The boron neutron capture therapy market size is expected to see rapid growth in the next few years. It will grow to $0.28 billion by 2030 at a compound annual growth rate (CAGR) of 17.7%. The growth in the forecast period can be attributed to growing adoption of precision medicine approaches, increasing shift toward targeted cancer therapies, expansion of accelerator-based BNCT systems, rising investment in oncology R&D infrastructure, increasing regulatory approvals for advanced radiotherapy techniques. Major trends in the forecast period include rising adoption of accelerator-based BNCT systems, growing use of next-generation boron delivery agents, increasing focus on precision oncology treatment methods, expansion of neutron beam optimization technologies, rising clinical trials for brain and extracranial tumor applications.

Global Boron Neutron Capture Therapy Market Segmentation

1) By Type: Thermal Beam, Epithermal Beam 2) By Boron Agent Type: Boronophenylalanine (BPA), Sodium Borocaptate ( BSH), Next-Generation Boron Delivery Agents 3) By Technology: Reactor-Based Boron Neutron Capture Therapy, Accelerator-Based Boron Neutron Capture Therapy 4) By Application: Brain Tumor, Extracranial Tumor, Other Applications 5) By End-User: Hospitals, Cancer Research Institutes, Specialty Clinics, Other End-Users Subsegments: 1) By Thermal Beam: Thermal Neutron Beam Delivery Systems, Thermal Neutron Treatment Platforms 2) By Epithermal Beam: Epithermal Neutron Beam Delivery Systems, Epithermal Neutron Treatment Platforms

What Is The Driver Of The Boron Neutron Capture Therapy Market?

The increasing global prevalence of cancer is expected to propel the growth of the boron neutron capture therapy market going forward. Cancer is a condition in which abnormal cells grow uncontrollably and spread within the body, disrupting and damaging normal tissues. The growing incidence of cancer is driven by lifestyle risk factors such as tobacco use, poor diet, and physical inactivity, which cause chronic inflammation and genetic mutations that increase cancer risk over time. Boron neutron capture therapy supports cancer treatment by providing a targeted radiation approach that selectively destroys tumor cells while minimizing damage to surrounding healthy tissues, making it suitable for difficult or recurrent cancers. For instance, in February 2024, according to the World Health Organization, a Switzerland-based global health agency, over 35 million new cancer cases are predicted in 2050, a 77% increase from the estimated 20 million cases in 2022. Therefore, the increasing global prevalence of cancer is driving the growth of the boron neutron capture therapy industry.

Key Players In The Global Boron Neutron Capture Therapy Market

Major companies operating in the boron neutron capture therapy market are Hitachi Ltd., Mitsubishi Heavy Industries Ltd., Sumitomo Heavy Industries Ltd., RaySearch Laboratories AB, Toshiba Energy Systems & Solutions Corporation, Cancer Intelligence Care Systems Inc., Neuboron Medtech Ltd., TAE Life Sciences LLC, Neutron Therapeutics Inc., Katchem Ltd., Stella Pharma Corporation, Fukushima SiC Applied Engineering Inc., International Particle Therapy Inc., Aviko Radiopharmaceuticals Sp. z o.o., Helsinki University Hospital, University of Wisconsin–Madison.

Global Boron Neutron Capture Therapy Market Trends and Insights

Major companies operating in the boron neutron capture therapy market are focusing on advancing novel boron delivery agents to enhance tumor targeting, improve imaging accuracy, and support effective therapeutic outcomes. Novel boron delivery agents are specialized compounds engineered to selectively deliver and concentrate boron in tumor cells, enhancing precision and therapeutic effectiveness in boron neutron capture therapy. For instance, in January 2025, Neuboron Medtech Ltd., a China -based R&D-oriented medical technology company, achieved IND approval for ¹⁸F-BPA, marking a key regulatory milestone in BNCT development. This highlights a rare combination of regulatory progress and clinical advancement, accelerating the translation of BNCT from research to real-world oncology applications.

What Are Latest Mergers And Acquisitions In The Boron Neutron Capture Therapy Market?

In November 2024, TAE Life Sciences, a US-based provider of boron neutron capture therapy technology, entered into a strategic collaboration with Stella Pharma Corporation to advance BNCT development. With this collaboration, both companies aim to accelerate the development and global deployment of boron neutron capture therapy solutions. Stella Pharma Corporation is a Japan-based provider of boron-based pharmaceutical products and cancer treatment drugs, including boronophenylalanine formulations used in boron neutron capture therapy for targeted cancer treatment.

Regional Insights

Asia-Pacific was the largest region in the boron neutron capture therapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Boron Neutron Capture Therapy Market?

The boron neutron capture therapy market consists of revenues earned by entities by providing services such as targeted cancer treatment using neutron irradiation, patient treatment planning, neutron beam delivery, and clinical oncology services related to boron neutron capture therapy (BNCT). The market value includes the value of related goods sold by the service provider or included within the service offering. The boron neutron capture therapy market also includes sales of boronophenylalanine (bpa), sodium borocaptate (bsh), neutron beam accelerator system, neutron beam accelerator system and research nuclear reactor systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Boron Neutron Capture Therapy Market Report 2026?

The boron neutron capture therapy market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the boron neutron capture therapy industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.